February 2012 Drug Update Information - Pharmacy Benefits ...

More documents

Recommendations

Info

Ondansetron 32 mg/50 mL premixed bags Hospira has ondansetron premixed bags on shortage due to changes in the manufacturing process. Claris recalled all lots of their ondansetron premixed bags in mid-2010. Pfizer discontinued their ondansetron premixed bags in January, 2012. Sagent has discontinued their ondansetron premixed bags. Teva has ondansetronn premixed bags on shortage due to manufacturing delays. West-Ward has discontinued their ondansetron premixedd bags. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=510 Source: http://www.a ashp.org Metformin Oral Tablets February 3, 2012 Products Affected - Description Metformin tablets, Amneal 500 mg extended release, 90 count (NDC 53746-0178-90) - discontinued Metformin tablets, Apotex 500 mg, 100 count (NDC 60505-0190-00) 500 mg, 500 count (NDC 60505-0190-01) 500 mg, 1000 count (NDC 60505-0190-08) 500 mg, 4500 count (NDC 60505-0190-04) 850 mg, 100 count (NDC 60505-0191-00) 850 mg, 500 count (NDC 60505-0191-01) 850 mg, 1000 count (NDC 60505-0191-08) 850 mg, 2500 count (NDC 60505-0191-04) 1000 mg, 100 count (NDC 60505-0192-00) 1000 mg, 500 count (NDC 60505-0192-01) 1000 mg, 1000 count (NDC 60505-0192-08) 1000 mg, 2000 count (NDC 60505-0192-04) 500 mg extended release, 100 count (NDC 60505-0260-01) 500 mg extended release, 500 count (NDC 60505-0260-02) 750 mg extended release, 100 count (NDC 60505-1329-01) Metformin tablets, Glenmark 1000 mg, 1000 count (NDC 68462-0161-10) Metformin tablets, Mutual Pharmaceuticals 500 mg, 100 count (NDC 53489-0467-01) - discontinued d 500 mg, 500 count (NDC 53489-0467-05) - discontinued d 500 mg, 1000 count (NDC 53489-0467-10) - discontinued 850 mg, 100 count (NDC 53489-0468-01) - discontinued d 850 mg, 500 count (NDC 53489-0468-05) - discontinued d 850 mg, 1000 count (NDC 53489-0468-10) - discontinued 1000 mg, 100 count (NDC 53489-0469-01) - discontinued 1000 mg, 500 count (NDC 53489-0469-05) - discontinued 1000 mg, 1000 count (NDC 53489-0469-10) - discontinued Metformin tablets, Mylan 500 mg, 100 count (NDC 00378-0234-01) 850 mg, 100 count (NDC 00378-0240-01) 750 mg extended release, 100 count (NDC 00378-0350-01) 500 mg, 500 count (NDC 00378-0234-05) - discontinued d 500 mg extended release, 100 count (NDC 00378-0352-01) - discontinued 50
500 mg extended release, 500 count (NDC 00378-0352-05) - discontinued Metformin tablets, Ranbaxy 500 mg, 100 count (NDC 63304-0860-01) - discontinued d 500 mg, 500 count (NDC 63304-0860-05) - discontinued d 750 mg, 100 count (NDC 63304-0767-01) - discontinued d Metformin tablets, Sandoz 500 mg, 12 x 60 package (NDC 00781-5050 -61) 850 mg, 12 x 60 package (NDC 00781-5051 -61) 1000 mg, 12 x 60 package (NDC 00781-5052-61) Metformin tablets, Teva 500 mg, 100 count, unit dose (NDC 00093-1048-93) - discontinued 850 mg, 100 count, unit dose (NDC 00093-1049-93) - discontinued 1000 mg, 100 count, unit dose (NDC 00093-7214-93) - discontinuedd Metformin tablets, UDL 850 mg, 100 count, unit-dose (NDC 51079-0973-20) - discontinued 500 mg, 25 count, unit-dose (NDC 51079-0972-19) - discontinued 500 mg, 100 count, unit-dose (NDC 51079-0972-20) - discontinued 500 mg, 300 count, unit-dose (NDC 51079-0972-56) - discontinued Metformin tablets, Watson 850 mg, 1000 count (NDC 62037-0675-10) - discontinued 1000 mg, 1000 count (NDC 62037-0676-10) - discontinued Reason for the Shortage Mylan, UDL, and Teva could not provide a reason for the shortage. Apotex has metformin products unavailable due to an FDA import ban. Sandoz has metformin products on shortage due to manufacturing delays. Ranbaxy has all discontinued metformin oral tablets. Mutual discontinued all metformin products. Teva discontinued metformin unit dose presentations in early-August, 2011. UDL discontinued metformin 500 mg 100 unit dose presentation in late-July, 2011. Watson discontinued d metformin 850 mg and 1000 mg presentations. . Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=731 Source: http://www.a ashp.org Lorazepam injectable presentations February 3, 2012 Products Affected - Description Lorazepam 2 mg/mL, Akorn 1 mL vial (NDC 17478-0040-01) Lorazepam 2 mg/mL, Bedford 1 mL vial (NDC 55390-0168-10) - discontinued 10 mL vial (NDC 55390-0170-10) - discontinued Lorazepam 4 mg/mL, Bedford 1 mL vial (NDC 53390-0169-10) - discontinued 10 mL vial (NDC 53390-0171-10) - discontinued Lorazepam 2 mg/mL, Hospira 1 mL iSecure prefilled syringes (NDC 00409-1985-05) - discontinued 1 mL Carpuject syringes (NDC 00409-1985- -30) 1 mL vial (NDC 00409-6778-02) 10 mL vials (NDC 00409-6780-02) Lorazepam 4 mg/mL, Hospira 51
Page 1 and 2: February 2012 Drug Information Upda
Page 3 and 4: GENERIC DRUG NAME GENERIC APPROVAL
Page 5 and 6: CICLOPIROX/ TOPICAL PEDIPIROX-4 New
Page 7 and 8: [Posted 01/09/2012] ISSUE: Novartis
Page 9 and 10: Studies Article Link: http://www.fd
Page 11 and 12: the use of XARELTO® (rivaroxaban),
Page 13 and 14: acteria. The Food and Drug Administ
Page 15 and 16: Statins raise risk of Type 2 diabet
Page 17 and 18: The Million Women Study, a U.K. pro
Page 19 and 20: Azithromycin 250 mg tablets, 1 card
Page 21 and 22: RECALLING FIRM/MANUFACTURE Recallin
Page 23 and 24: Recalling Firm: Pfizer Us Pharmaceu
Page 25 and 26: 250 mg, 100 count (NDC 00591-3969-0
Page 27 and 28: Sandoz states the shortage is due t
Page 29 and 30: 5 mL ampule (NDC 10019-0033-72) 20
Page 31 and 32: Article Link: http://www.ashp.org/D
Page 33 and 34: Lidocaine 2% (with epinephrine 1:10
Page 35 and 36: Source: http://www.a ashp.org Halop
Page 37 and 38: ecome unavailable for an extended t
Page 39 and 40: American Regent resumed manufacturi
Page 41 and 42: Trandate tablets, Prometheus 100 mg
Page 43 and 44: Article link: http://www.ashp.org/D
Page 45 and 46: Bedford Laboratories has multiple p
Page 47 and 48: Thiothixene capsules, Mylan 2 mg ca
Page 49: 20 mL vials (NDC 10019-0905-03) - d
Page 53 and 54: 1 mg/mL, 4 mL vial (NDC 25021-0781-
Page 55 and 56: West-Ward states the shortage is du
Page 57 and 58: 150 mL bottle (NDC 63304-0954-02) C

February 2012 Drug Update Information - Pharmacy Benefits ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?